General Information of the Compound
| Compound ID |
CP0303870
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-Propyl-3,7-dihydro-purine-2,6-dione
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-Propyl-3,7-dihydro-purine-2,6-dione
1-Propylxanthine
1-propyl-3,7-dihydropurine-2,6-dione
104285-82-7
1H-Purine-2,6-dione, 3,7-dihydro-1-propyl-
1H-Purine-2,6-dione,3,9-dihydro-1-propyl-
AC1L2TY0
ACMC-1BNN6
BDBM50001490
CHEMBL39986
CTK4A2909
DTXSID10146367
IWBONKMODGBEOX-UHFFFAOYSA-N
SCHEMBL4423680
SCHEMBL8930198
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C8H10N4O2
|
||||||||||||||||||
| Molecular Weight |
194.194
|
||||||||||||||||||
| Canonical SMILES |
CCCn1c(=O)[nH]c2nc[nH]c2c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C8H10N4O2/c1-2-3-12-7(13)5-6(10-4-9-5)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,14)
Show/Hide
|
||||||||||||||||||
| InChIKey |
IWBONKMODGBEOX-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
104285-82-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01717, Adenosine receptor A1
Protein ID: PT01278, Adenosine receptor A2b
Protein ID: PT02131, Adenosine receptor A2b
Clinical Information about the Compound